3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Nervous System Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaghan, CA; Costigan, MG; Lindup, WE | 1 |
1 trial(s) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Nervous System Disorders
| Article | Year |
|---|---|
Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
Topics: Furans; Humans; Kidney Failure, Chronic; Nervous System Diseases; Peritoneal Dialysis, Continuous Ambulatory; Propionates; Renal Dialysis | 1996 |